Adapted Frenkle Exercises Versus Dynamic Balance Training in School Going Children (DBT)

June 1, 2026 updated by: Riphah International University

Comparison of Adapted Frenkel Exercises and Dynamic Balance Training on Balance, Gait, Mobility, and Motor Coordination in School-Going Children

A randomized clinical trial will be conducted at Realm Educational School. Children aged 6-12 years will be randomly assigned to either the AFE or DBT group using convenient sampling. Participants must be physically active and free from neurological, orthopedic, or cognitive impairments, while those with sensory impairments or recent musculoskeletal injuries will be excluded. Outcome measures will include the Pediatric Balance Scale (PBS), Y-Balance Test, Observational Gait Scale (OGS), Timed Up and Go (TUG) test, and BOT-2. Pre- and post-intervention assessments will evaluate the effectiveness of both interventions on balance, gait, mobility, and motor coordination.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Balance, gait, mobility, and motor coordination are essential for the physical and functional development of school-going children and influence their participation in academic, recreational, and daily activities. The ages of 6-12 years represent a critical period for neuromuscular and postural maturation, making early motor interventions particularly effective. Deficits in these skills may result in reduced physical activity, poor posture, and social withdrawal. This study compares Adapted Frenkel Exercises (AFE), which focus on slow, visually guided, and controlled movements to enhance coordination and proprioception, with Dynamic Balance Training (DBT), which uses functional, task-specific activities such as balance beam walking, multidirectional stepping, and hopping to improve stability during movement. A randomized clinical trial will be conducted at Realm Educational School over 10 weeks (2 sessions per week). Each session will be of 40 minutes. Children aged 6-12 years will be randomly assigned to either the AFE or DBT group using convenient sampling. Participants must be physically active and free from neurological, orthopedic, or cognitive impairments, while those with sensory impairments or recent musculoskeletal injuries will be excluded. Outcome measures will include the Pediatric Balance Scale (PBS), Y-Balance Test, Observational Gait Scale (OGS), Timed Up and Go (TUG) test, and BOT-2. Pre- and post-intervention assessments will evaluate the effectiveness of both interventions on balance, gait, mobility, and motor coordination.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Healthy school-going children aged 8-10 years
  2. Both male and female participants
  3. No history of neurological, orthopedic, or developmental disorders
  4. Informed parental consent and child assent obtained
  5. MMSE score ≥ 24
  6. TUG score < 20 seconds
  7. Pediatric Berg Balance Scale score ≥ 40

Exclusion Criteria:

  1. History of diagnosed balance or coordination issues.
  2. Children with orthopedic and motor impairments.
  3. Behavior or attention disorders limiting participation.
  4. Neuromuscular conditions, Visual and mental disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adapted Frenkle Exercises
For 10 weeks, 40 minutes session, twice a week. Frenkle Exercises will be perform from simple to complex ones. These are coordinated exercises that improve motor function, proprioception and balance.

Participants will receive adapted Frenkel exercises progressing from simple to complex movements, focusing on controlled, precise lower-limb movements to improve coordination and balance.

Sitting: Controlled leg movements (side leg placement to floor markers, drawing shapes with toes, slow leg lifts).

Standing: Marching in place, side leg lifts, and controlled weight shifting. Walking drills: Straight-line walking with visual cues, step-and-stop walking, and figure-8 walking to negotiate obstacles.

Experimental: Dynamic Balance Training
For 10 weeks, dynamic balance training will be performed for 40 minutes in each session. These activities involve the sensory system and require muscle power and coordination.

Participants will receive dynamic balance training emphasizing postural control, coordination, strength, and functional balance through varied movement tasks.

Mat-based balance exercises Rope activities (e.g., jumping) Balance equipment and ground-based balance tasks Paired movements, rhythm and coordination activities, stepping stones, and non-dominant limb tasks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Balance Scale
Time Frame: 10 weeks
Assesses functional balance in children through 14 task-based items. Scale Range: 0-56 Interpretation: Higher scores indicate better balance performance.
10 weeks
Y Balance Test - Pediatric version
Time Frame: 10 weeks

The Y Balance Test is a dynamic balance assessment that measures a child's ability to maintain single-leg stance while reaching in three directions: anterior, posteromedial, and posterolateral.

Scale Range: Reach distance measured in centimeters (%) normalized to limb length.

Interpretation: Higher reach distances indicate better dynamic balance and postural control.

10 weeks
Observational Gait Scale
Time Frame: 10 weeks

Evaluates gait parameters, including stance, swing, and foot placement during walking.

Scale Range: 0-22 Interpretation: Higher scores indicate better gait performance.

10 weeks
Timed Up and Go Test
Time Frame: 10 weeks

Measures functional mobility and dynamic balance during sit-to-stand, walking, turning, and sitting.

Scale Range: Measured in seconds (no fixed minimum or maximum score). Interpretation: Lower completion times indicate better functional mobility and balance performance.

10 weeks
Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) - Selected subtests
Time Frame: 10 weeks
Assesses gross motor coordination, bilateral coordination, and balance in children.
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mehwish Javed, MS-PPT, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

December 14, 2025

First Submitted That Met QC Criteria

June 1, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RiphahIU- Mehwish

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Children

Clinical Trials on Adapted Frenkle Exercises

Subscribe